Search

everythinglearnresearchcommunity

for

Search:↓

VEGFR-2 is active in hair follicles, sebaceous glands, sweat glands, and skin on the human scalp.

Targeting the PGD2-DP2 pathway may help treat hair loss.

The document concludes that MGRN1 affects mouse fur color by interfering with a receptor's signaling, but its full role in the body is still unknown.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

PGF_2α receptors in human eyelids are found in specific parts of hair follicles, explaining eyelash changes with glaucoma treatment.

A substance called 15-deoxy prostaglandin J2 can cause hair follicle cells to die, which might explain how prostaglandin D2 can lead to hair loss.

A specific RNA, circNlgn, contributes to heart damage and scarring caused by the cancer drug doxorubicin.

EGFR is essential for organized skin nerve growth and branching.

Par3–mInsc and Gαi3 work together to ensure proper cell division orientation in skin development.

BMP-2 activates the Dlx3 gene in mouse skin cells, important for hair and skin development.

Dopaminergic neurons in the gut have distinct subtypes, some releasing both dopamine and acetylcholine.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Blocking the KATP channel may help treat migraines.

VEGFR-2 activation is likely involved in hair follicle growth, survival, and development.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Dkk4 protein helps control how hair grows and its arrangement.

Topical IKKα inhibitors may help prevent CCS tumours.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Finasteride helps female-pattern hair loss.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Mutations in certain receptors can cause diseases and offer new treatment options.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Phospholipids help plant proteins move by regulating receptor interactions.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Removing certain brain receptors in mice worsens seizure severity and response to treatment during hormone withdrawal.